Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats

MLA

Han-Chieh, Lin, et al. “Beneficial Effects of Dual Vascular Endothelial Growth Factor Receptor/Fibroblast Growth Factor Receptor Inhibitor Brivanib Alaninate in Cirrhotic Portal Hypertensive Rats.” Journal of Gastroenterology and Hepatology, vol. 29, no. 5, Nov. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........9834f516c79f97166c502b393a8be03d&authtype=sso&custid=ns315887.

APA

Han-Chieh, L., Yi-Tsau, H., Ying-Ying, Y., Pei-Chang, L., Lih-Hwa, H., Wei-Ping, L., Ying-Ju, K., Kuei-Chuan, L., Yun-Cheng, H., & Ren-Shyan, L. (2013). Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats. Journal of Gastroenterology and Hepatology, 29(5).

Chicago

Han-Chieh, Lin, Huang Yi-Tsau, Yang Ying-Ying, Lee Pei-Chang, Hwang Lih-Hwa, Lee Wei-Ping, Kuo Ying-Ju, Lee Kuei-Chuan, Hsieh Yun-Cheng, and Liu Ren-Shyan. 2013. “Beneficial Effects of Dual Vascular Endothelial Growth Factor Receptor/Fibroblast Growth Factor Receptor Inhibitor Brivanib Alaninate in Cirrhotic Portal Hypertensive Rats.” Journal of Gastroenterology and Hepatology 29 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........9834f516c79f97166c502b393a8be03d&authtype=sso&custid=ns315887.